| |
International Adviser - longevity investing turns to mark-to-market
July 2011
David Rawson-Mackenzie explains why Centurion has recently moved to a mark-to-market valuation model for its longevity funds.
|
Investment Week - Will longevity be the next innovative retail asset class?
January 2011
David Rawson Mackenzie writes about how longevity as an asset class has typically appealed more to institutional investors but will start appealing to retail investors too. "Investing in longevity is not just for investors with degrees in quantum finance." he argues.
|
Investment Adviser - Safe returns in a volatile era from life settlement funds
September 2010
In a recent article in Investment Adviser, David Rawson Mackenzie demonstrates how life settlement funds can offer reassuring stability for sophisticated investors looking for steady returns in an uncertain and potentially turbulent market place.
|
International Adviser - Getting more out of life
July 2010
David Rawson-Mackenzie, founder and managing director of Centurion Group, offers an overview of how life settlements work as an investment tool and how they can help to diversify an investment portfolio in July edition of International Advisor.
|
Financial Planner - Striving for a secure life
July 2010
David Rawson-Mackenzie, founder and managing director of Centurion Group, comments on the progress to securitisation of life settlement policies in July edition of Financial Planner Magazine.
|
International Adviser - Evaluating risk in a life settlement fund
November 2009
David Rawson-Mackenzie, director of Centurion Fund Managers, explains how to evaluate the risks in a life settlement fund. As with a lot of alternative investment funds, it is often difficult for outside investors to evaluate all the risks, and a life settlement fund is no exception. The article analyses the common risks associated to a life settlement fund and how Centurion mitigates them.
|
HFM Week - Investing in life settlements
December 2009
As we begin to see a higher degree of transparency and convergence in life expectancy estimates, David Rawson-Mackenzie shows how life settlement funds can tailor their needs by using synthetics structured either as longevity or mortality notes.
|
Life & Pensions - Choose Life
October 2009
The US life settlements sector is marketing itself to pension funds and European insurers as an easy way to add diversification to a portfolio. The article provides an overview of the asset class and its benefits for pension funds.
|
STORM - Synthetically speaking
September 2009
David Rawson-Mackenzie, director of Centurion Fund Managers, was interviewed by STORM and explained how Centurion uses customised synthetic products to optimise its longevity funds and enhance liquidity management.
|
Financial Adviser - Extend the lifeline
November 2009
In this article, David Rawson-Mackenzie analysis longevity as an asset class. The article explains the difference between micro and macro longevity and it also reviews the key elements to have in mind when investing in this asset class.
|
Investment Week - Sales of the unexpected
August 2009
The article explains why in life settlement funds, accurate valuation methodologies are needed to ensure fairness to all shareholders and to maintain sufficient liquidity. Successful fund managers in this asset class have developed solid valuation methodologies.
|
International adviser - life settlement fund taxation
July 2009
An explanation of the significance for life settlement fund investors of the recent US Internal Revenue Service rulings on the taxation of death benefits from life insurance policies.
|
Professional Wealth Management - Introduction to synthetic micro-longevity instruments
March 2009
David Rawson-Mackenzie and Pollyanna Wan examine synthetic micro-longevity instruments as a longevity asset which is steadily gaining popularity as investors seek greater diversification
|